This bill would require that a hospital shall maintain a metal detector at each point of entry into the hospital.
HB 4146 (Fine/Steans) amends the Managed Care Reform and Patient Rights Act. During an enrollee's plan year, prohibits a health care plan from removing a drug from its formulary or negatively changing its preferred or cost-tier sharing unless, at least 60 days before making the formulary change, the health care plan provides certain notifications to current and prospective enrollees and prescribing providers. After session-long negotiations, an amendment was adopted that preserved patient access to drugs but still allowed a health plan to make formulary changes. The bill passed both the House and Senate the last week of session.
SB 682 requires that an insurance policy provide unlimited benefits for inpatient and outpatient treatment of mental, emotional, nervous, or substance use disorders or conditions. This would significantly add to health insurance costs. The Chamber was opposed to this legislation. We successfully negotiated a compromise that removed prior authorization for substance abuse treatments, but preserved a health plan’s ability to ensure that treatments are medically necessary.
HB 68 (Lang) was a particularly anti-business bill that created a private right of action to sue health plans to enforce state mental health parity laws. The Chamber led negotiations on behalf of employers and commercial insurers, which resulted in an acceptable amendment that codifies additional enforcement provisions at the Department of Insurance as well as creates a workgroup to study insurance reporting requirements regarding mental health parity. The language was attached to SB1707 and passed both the Illinois House and Senate after the Chamber went neutral
HB 4900 (Guzzardi) regulates generic drug price “gouging” and brings the government into the decision-making process regarding how pharmaceuticals are priced. The Chamber opposed and testified against the legislation in committee. The House passed the bill, but was never called in committee in the Senate.
HB 3479 (Feigenholtz/Manar) would mandate pharmacy reimbursement rates for Medicaid (and a filed amendment would extend that provision to private health plans). The Chamber believes that reimbursement rates should remain a contractual and market-based provision and not legislatively mandated. The bill passed the House but was never taken up for a final vote in the Senate.
This legislation expanded the scope of practice for physical therapists to include dry needling. The Chamber successfully negotiated language that would ensure that employers do not have to cover the experimental treatment.
Creates the independent quasi-judicial Health Insurance Rate Review Board to ensure insurance rates are reasonable and justified. Sets forth duties and prohibited activities concerning the Board. Provides that the Board shall review and approve or disapprove all rates and rate schedules filed or used by a health carrier. Sets forth provisions concerning rate standards, public notice, hearings, and the disapproval and approval of rates and rate schedules.
This bill is a pre-existing condition insurance mandate, passed by both houses. The bill as passed, adopted an amendment that clarified the mandate did not apply to short-term travel, disability income, long-term care, accident only, or limited or specified disease policies.
Insurance mandate on hearing instruments.
Amends the Illinois Insurance Code, the State Employees Group Insurance Act of 1971, the Counties Code, the Illinois Municipal Code, the School Code, the Health Maintenance Organization Act, the Limited Health Service Organization Act, and the Voluntary Health Services Plans Act. Prohibits insurers from requiring that a covered individual first use an opioid analgesic drug product without abuse-deterrence labeling claims before providing coverage for an abuse-deterrent opioid analgesic drug product.